» Articles » PMID: 6161973

Sensitivity of Herpes Simplex Virus Types 1 and 2 to Three Preparations of Human Interferon

Overview
Journal J Infect Dis
Date 1980 Dec 1
PMID 6161973
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Ten isolates of herpes simplex virus (HSV) type 1 and nine isolates of HSV type 2 were tested against virus-induced (alpha), fibroblast (beta), and mitogen-induced (gamma) preparations of human interferon (HuIFN). HSV type 2 was slightly more sensitive and HSV type 1 somewhat less sensitive to all three preparations of HuIFN than Sindbis and vesicular stomatitis virus-both considered to be quite sensitive to HuIFN. HSV type 2 was significantly more sensitive than HSV type 1 to each of the HuIFN preparations (P less than 0.01; Mann-Whitney ranksum test). Clinical isolates did not appear to differ from laboratory strains. These results indicate that both HSV types 1 and 1 are sensitive to the three different preparations of HuIFN. HuIFN may have a role in natural recovery from and may have potential as an antriviral chemotherapeutic agent in HSV infections in humans.

Citing Articles

Current recommendations for the treatment of genital herpes.

Leung D, Sacks S Drugs. 2001; 60(6):1329-52.

PMID: 11152015 DOI: 10.2165/00003495-200060060-00007.


Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.

Ryman K, Klimstra W, Nguyen K, Biron C, Johnston R J Virol. 2000; 74(7):3366-78.

PMID: 10708454 PMC: 111838. DOI: 10.1128/jvi.74.7.3366-3378.2000.


Biosynthetic human interferon treatment of herpetic keratitis.

Smolin G Trans Am Ophthalmol Soc. 1983; 81:785-824.

PMID: 6676984 PMC: 1312468.


Interferon susceptibility of herpes simplex virus strains isolated from patients enrolled in clinical trials.

Armstrong J, BREINIG M, Ho M Antimicrob Agents Chemother. 1983; 24(1):137-9.

PMID: 6312872 PMC: 185119. DOI: 10.1128/AAC.24.1.137.


Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Dix R, McKendall R, Baringer J Infect Immun. 1983; 40(1):103-12.

PMID: 6299955 PMC: 264823. DOI: 10.1128/iai.40.1.103-112.1983.